Related Experiment Video
Updated: Sep 30, 2025
08:28
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
319
A Reference Standard for Analytical Testing of Erythropoietin.
Huiping Tu1, Kevin Carrick1, Rebecca Potts1
1United States Pharmacopeial Convention, 12601 Twinbrook Pkwy, Rockville, Maryland, 20852, USA.
Pharmaceutical Research
|March 16, 2022
Summary
A new recombinant human erythropoietin (rHuEPO) reference standard was developed and validated. This standard ensures the quality and consistency of rHuEPO products, crucial for anemia treatment.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Pharmacology
Background:
- Erythropoietin (EPO) is vital for red blood cell production; deficiencies cause anemia.
- Recombinant human EPO (rHuEPO) treats anemia but requires rigorous quality control.
- Reference standards are essential for validating analytical methods for rHuEPO.
Purpose of the Study:
- To develop and characterize a high-quality reference standard for rHuEPO.
- To ensure the reliability of analytical methods used in rHuEPO manufacturing.
Main Methods:
- Peptide mapping was employed for detailed protein analysis.
- Size-exclusion chromatography assessed molecular size and aggregation.
- Glycoprofiling analyzed glycosylation patterns.
- Isoelectric focusing determined charge heterogeneity.
Main Results:
- The characterized rHuEPO reference standard demonstrated high quality.
- Analytical results confirmed the standard's suitability for its intended purpose.
Conclusions:
- The developed rHuEPO reference standard is fit for purpose.
- It serves as a critical tool for validating system suitability and analytical methods.
- This contributes to ensuring the safety and efficacy of rHuEPO therapeutics.
